Saturday, February 16, 2019
    Latest

    Cancer

    Home Cancer
    Multiple Myeloma
    Cancer

    TrialWatch: Sanofi’s Isatuximab Extends Time Without Cancer Progession in Phase 3...

    0
    Cancer Grant
    Cancer

    Genkyotex Wins Grant from Cancer Research UK

    0
    Antibodies
    Cancer

    Stanford Studies Antibody that Represents Possible Cure for Blood, Immune Disorders

    0
    Cancer

    TamRx Launched to Develop Immuno-Oncology Pipeline to Treat Cancers

    0
    Cancer

    Illinois Institute of Tech Announces Chicago-based Cancer Imaging Team Wins Competition

    0
    Cancer
    Cancer

    Biotech Venture LIDDS Approved Launches Scandinavian Phase I Clinical Trial

    0
    Magnetic Resonance Radiation Therapy
    Cancer

    MOMENTUM Study Launched to Learn from Cancer Patients Treated with Magnetic...

    0
    Bacon Alcohol Cancer
    Cancer

    World Cancer Research Fund Study Reveals Cut Bacon & Booze and...

    0
    NSE
    Cancer

    Newly Discovered Combination Therapy Used in Phase I Cancer Trials with...

    0
    Cancer

    Israeli Researchers Pursue Cancer Cures

    0
    123...5Page 1 of 5
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved